Malignant fibrous histiocytoma (MFH) is a soft tissue sarcoma mainly occurring in the soft tissues, especially in the extremities and trunk, and other less common sites include the retroperitoneum, and the head and neck.[@ref1]--[@ref3] It is an aggressive malignancy with high potential of local recurrence and distant metastases, and surgery with radical resection of the primary tumor with histo-logical negative margins is the treatment of choice even with recurrence or metastasis.[@ref1][@ref4][@ref5] MFH of the spleen is extremely rare, although the incidence of splenic MFH remains undetermined, only 13 cases have been reported in the English language literature in Medline.[@ref6]--[@ref17] Because of its rarity, the clinical characteristics and biological potentials of MFH of the spleen are yet to be determined.

We herein report a 48-year-old Chinese female with MFH of the spleen accompanying with hepatic cyst, which has not yet been reported in the literature. To the best of our knowledge, this case is the first case of MFH of the spleen accompanied with other disease, and also the first case treated successfully by laparoscopic splenectomy. A literature review of MFH of the spleen previously reported in the English language literature in Medline is also provided.

Case Report {#sec1-1}
===========

A 48-year-old Chinese female was admitted to Department of Oncological Surgery (Zhejiang Cancer Hospital, Hangzhou) with left upper abdominal pain, accompanying with belching and weight loss of 2.5 kg over the previous 3 months. Prior to this presentation, she had been healthy, without any previous medical illness. On physical examination, the left upper quadrant was slight tender but no abdominal mass was detected by abdominal palpation. Laboratory data were all normal. Computed tomography (CT) demonstrated a low-density mass with a CT value of 1 Hounsfield Unit (HU), measuring about 3.2 × 2.2 cm in the right lobe of liver ([Figure 1A](#F1){ref-type="fig"}), and a solid low-density mass with a CT value of 8HU, measur-ing about 5.2 cm × 4.6 cm in the upper pole of the spleen ([Figure 1B](#F1){ref-type="fig"}).

![CT demonstrated a low-density mass measuring about 3.2 cm × 2.2 cm in the right lobe of liver (A), and a solid low-density mass measuring about 5.2 cm × 4.6 cm in the upper pole of the spleen (B).](JRMS-16-963-g001){#F1}

Based on the physical examination and CT, the preoperative diagnosis of the hepatic cyst was definite but the preoperative diagnosis of the splenic tumor was difficult. Then a laparo-scopic splenectomy was performed under a presumed diagnosis of a malignancy of the spleen. Intraoperatively, a solid mass ap-proximately 5 cm in diameter was found in the upper pole of the spleen. Intra-abdominal lymph nodes and the adjacent organs looked normal. There were not any signs of metasta-ses or any visible neoplastic tissue remnant at the operation site. Laparoscopic fenestration of the hepatic cyst was also performed. The re-sected spleen measured 11 × 10 × 8 cm, weighed 740 g. Histopathology showed that tumor cells were pleomorphic and consisted of fibroblasts, histiocytes, and myofibroblast-like cells arranged in a storiform pattern ([Figure 2A](#F2){ref-type="fig"}). Immunohistochemistry showed these tu-mor cells were positive for vimentin (Vim), α-smooth muscle actin (α-ACT) and CD68 ([Figure 2B](#F2){ref-type="fig"}). Based on these results of histopathology and immunohistochemistry, the final diagnosis of MFH of the spleen was conformed. The postoperative course of this patient was uneventful. The patient was discharged on the 7th day after the initial operation and was not given any additional treatment. She was followed up for 13 months without recurrence or metastases after the initial surgery at the time of reporting.

![Histopathology showed tumor cells were pleomorphic and consisted of fibroblasts, histiocytes, and myofibroblast-like cells arranged in a storiform pattern (A). Immunohistochemistry showed tumor cells were positive for CD68 (B). (HE: 200×)](JRMS-16-963-g002){#F2}

Discussion {#sec1-2}
==========

MFH is the most common soft tissue sarcoma mainly occurring in the extremities (70%), followed by the abdominal or retroperitoneum (16%).[@ref1] The origin of MFH is still controversial. Primary MFH of the spleen is extremely rare, although the incidence of MFH of the spleen remains undetermined. Since the first description of primary splenic MFH reported by Govoni *et al*.[@ref6] in 1982, only 13 cases have been reported in the English language literature in Medline.[@ref6]--[@ref17] Compared with the 13 previously reported cases of MFH of the spleen, our case was the first case of MFH of the spleen accompanied with other disease, and also the first case treated successfully by laparoscopic splenectomy.

The spleen, for poorly documented reasons, generally shows relative resistance to malignant tumors. Accordingly, the preoperative diagnosis of MFH of the spleen is difficult because the cases are extremely rare, the clinical symptoms are nonspecific, and the imaging patterns are not suggestive. The final diagnosis is confirmed by the result of the histopathology and immunohistochemistry. These tumor cells consist of histiocyte-like and fibroblast-like cells with other multinucleated giant cells.[@ref1][@ref13][@ref18] There are positive stainings for lysozyme, Vim, CD68, and α-1 antitrypsin.[@ref13] In our case, we could not get a definite preoperative diagnosis of the splenic tumor according to the physical examination and CT scanning. A final diagnosis of MFH of the spleen was confirmed by the histopathology and immunohistochemistry.

In review of the English language literature in Medline, we found 13 previously reported cases of the MFH of the spleen ([Table 1](#T1){ref-type="table"}). Among the 14 cases of MFH of the spleen, including our case, six cases were females and eight cases were males with the age from 35 to 82 years old, mainly in the fourth or fifth decade of life (9/14). The presenting symptoms were usually nonspecific, but the clinical characteristics such as abdominal pain, fever, weight loss, and splenomegaly were prominent features in about 70% of the patients.[@ref17] About 35.7% (5/14) of the cases with splenic MFH presented metastases at the initial surgery including liver (3 cases), stomach and pancreas (1 case), and omentum (1 case); and the liver was the most common metastatic site. MFH has been categorized into five types, based on the histopathologic subtype, including storiform-pleomorphic, myxoid, inflammatory, giant cell and angiomatoid variants.[@ref1][@ref6]--[@ref9][@ref13] However, only the subtype of storiformpleomorphic and inflammatory variants have been reported in the MFH of the spleen in the previously reported literature. In review of the 14 cases, although 4 cases were not mentioned, eight cases were storiform-pleomorphic types including our case and two cases were inflammatory types. All of the 14 patients underwent the surgery of splenectomy, while our case was the first case treated successfully by laparoscopic splenectomy. Four cases were also treated by adjuvant chemotherapy and/or radiotherapy. The survival time was mentioned in 13 cases. Six patients died of local recurrence with multiple metastasis, 3, 6, 7, 8, 15, and 19 months postoperatively. One patient was dead after splenectomy with hepatic involvement and the other was alive at 18 months with multiple hepatic metastases at the time of reporting. Five cases, including our case, survived for 3, 13, 17, 18, and 46 months, without local recurrence and distant metastasis at the time of reporting.
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Conclusion {#sec1-3}
==========

The incidence of splenic MFH remains undetermined due to limited data on a rare malignancy. The clinical symptoms of primary splenic MFH are usually nonspecific, but the characterics such as abdominal pain, fever, weight loss, and splenomegaly are prominent features. Splenectomy including laparoscopic splenectomy with histological negative margins is the treatment of choice. Chemotherapy and radiotherapy are other therapeutic modalities for patients with metastasis, but the therapeutic effect is poor.
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